Product logins

Find logins to all Clarivate products below.


Clarivate’s Pharma Industry Report provides pharma executives with a comprehensive summary of the current and future state of the global pharmaceutical industry.

Scope

This report pulls together key information about the global pharmaceutical market from across our Company & Drug Insights content. We analyze the top selling brands, companies, and therapeutic areas. We evaluate the leading competitors in terms of their ethical drug sales, strategic focus, current drivers, patent exposure, and pipeline projects. We compare the different therapeutic areas in terms of their global sales and highlight the leading competitors and pipeline drugs within each area to provide you with a comprehensive summary of the global market.

Companies Mentioned

  • AbbVie
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi-Sankyo
  • Eisai
  • Eli Lilly
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Merck KGaA
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Takeda
  • Teva
  • Vertex

Questions answered in this report

  • Who are the leading competitors in the global pharmaceutical industry? What are their current drivers and areas of R&D? What is their timeline for patent exposure?
  • How do the different therapy areas rank in terms of size and relative growth? How do their global sales break down by drug technology, and what are the leading pipeline projects?
  • What are the leading drugs according to global sales, and how will these rankings change by 2028?

 

Related Market Assessment Reports

Report
Multiple Myeloma – Geographic Focus: China – Multiple Myeloma – China In-Depth (China)
China’s multiple myeloma therapy market is evolving rapidly, driven by an increasing disease burden and advances in treatment options. Current therapies in China largely mirror global standards;…
Report
Hepatocellular Carcinoma – Geographic Focus: China – Hepatocellular Carcinoma – China In-Depth (China)
The hepatocellular carcinoma therapy market in China is poised to experience significant growth, driven by an aging population and the high prevalence of hepatitis B and C infection. Angiogenesis…
Report
Type 2 Diabetes – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)
Metformin remains the most heavily prescribed type 2 diabetes (T2D) drug and dominates the early lines of therapy before disease progression requires insulin replacement. More effective, safer, and…
Report
Atrial Fibrillation – Current Treatment – Treatment Algorithms: Claims Data Analysis – Atrial Fibrillation (US)
Atrial fibrillation (AF) is a common arrhythmia characterized by irregular, often rapid heartbeats in the atria, increasing the risk of stroke and cardiovascular complications. Management typically…
Report
Paroxysmal Nocturnal Hemoglobinuria – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder in which the immune system attacks red blood cells and platelets. PNH is characterized by intravascular hemolysis, venous…